Home Careers Contact

Price: 3.85

Change: 0.00

Day High: 3.85
Day Low: 3.75
Volume: 923,861

4:00 PM ET | May 26, 2017
Delayed 20 min., by eSignal.



Shareholder Tools

Committee Composition

  Audit Nominating and Governance Compensation
Garheng Kong, M.D., Ph.D Chairman of the Board Member of Audit Committee   Committee Chair for Compensation Committee
David Zaccardelli, Pharm.D.      
Richard Kent, M.D.     Member of Compensation Committee
David Gill Committee Chair for Audit Committee    
Dov A. Goldstein, M.D., M.B.A.   Committee Chair for Nominating and Governance Committee  

Dr. Goldstein serves as a Partner of Aisling Capital. Previously, Dr. Goldstein was Executive Vice President and Chief Financial Officer of Vicuron Pharmaceuticals up until its acquisition by Pfizer. While at Vicuron Pharmaceuticals, he raised over $250 million dollars in an IPO, PIPE, Follow-on, and block trade transactions. He led the valuation and finance due diligence for the merger with Biosearch Italia (Nuovo mercato: BIO.MI), the first US and Italian public to public company merger. He also ran the investor relations and press relations efforts for the company. Prior to Vicuron, Dr. Goldstein was Director of Venture Analysis at Healthcare Ventures. He also completed an internship in the Department of Medicine at Columbia-Presbyterian Hospital. Dr. Goldstein currently serves as a director of ADMA Biologics, Inc., Cempra Pharmaceuticals (NASDAQ: CEMP), Durata Therapeutics, Inc. and Esperion Therapeutics, Inc. Former investments include Topaz Pharmaceuticals (acquired by Sanofi). Dr. Goldstein received his M.D. from Yale School of Medicine. He received his M.B.A. from Columbia Business School and his B.S. with honors from Stanford University.


Holdings: 50 shares     View Transactions
John H. Johnson   Member of Nominating and Governance Committee  
P. Sherrill Neff     Member of Compensation Committee
Michael Dougherty Member of Audit Committee Member of Nominating and Governance Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair of the Committee Committee Member = Member

Stock transaction information provided by EDGAR Online. Cempra, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.